Late follow-up for a randomized trial of surgical treatment of tricuspid valve regurgitation in patients undergoing left ventricular assist device implantation
Michelle Mendiola(Duke Medical Center), Muath Bishawi(Emory University), Emily Poehlein(Duke University), Alina Nicoara(Duke Medical Center), Stuart D. Russell(Duke Medical Center), Han Billard(Duke Medical Center), Carmelo A. Milano(Duke University Hospital), Lillian Kang(Duke Medical Center), Mani A. Daneshmand(Emory University Hospital), Jacob N. Schroder(Duke University), Chetan B. Patel, Adam D. DeVore(Duke University), Benjamin S. Bryner(Northwestern University), Cynthia L. Green(Duke University), Frank Benedetti(Duke Medical Center), Yuting Chiang(Columbia University)
Cited by 5
Related Papers
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Medical Therapy for Heart Failure With Reduced Ejection Fraction
|Journal of the American College of Cardiology|2018|1.3k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients
|Journal of the American College of Cardiology|2010|583